Skip to main content

JANE STREET GROUP, LLC

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 1595888 NEW YORK, NY

Position in SLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,504,411
+$7,504,411 QoQ
Shares Held
508,429
Ownership
0.252%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 192 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Derivatives in SLS

reported options exposure · as of Jun 30, 2026
CallValue
$11,058,192
CallShares
749,200
PutValue
$2,405,880
PutShares
163,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. SLS ranks #30 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SLS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,405,880 163,000
2026-06-30 $11,058,192 749,200
2026-06-30 $7,504,411 508,429
2026-03-31 $1,030,005 243,500
2025-12-31 $1,065,779 282,700
2025-12-31 $224,450 59,536
2025-09-30 $165,763 102,959
2025-09-30 $203,182 126,200
2025-06-30 $457,272 208,800
2025-06-30 $102,233 46,682
2025-03-31 $63,223 58,541
2025-03-31 $142,128 131,600
2024-12-31 $12,795 12,304
2024-12-31 $40,040 38,500
2024-09-30 $43,750 35,000
2024-06-30 $33,312 27,994
2023-09-30 $18,092 11,032
2021-12-31 $86,821 15,700
2021-09-30 $186,560 20,367
2021-09-30 $146,560 16,000
2021-06-30 $455,100 41,000
2021-06-30 $153,180 13,800
2020-12-31 $112,499 19,363